RRC ID 52440
著者 Obata K, Shimo T, Okui T, Matsumoto K, Takada H, Takabatake K, Kunisada Y, Ibaragi S, Yoshioka N, Kishimoto K, Nagatsuka H, Sasaki A.
タイトル Role of Neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma.
ジャーナル Anticancer Res
Abstract BACKGROUND/AIM:The neurokinin 3 receptor (NK-3R) is differentially expressed in the central nervous system including cases of human oral squamous cell carcinoma. However, the role of NK-3R signaling in oral squamous cell carcinoma is not well known.
MATERIALS AND METHODS:NK-3R expression in surgically resected oral squamous cell carcinoma was examined immunohistochemically and the strength of the expression was quantified. We evaluated the function of NK-3R signaling using NK-3R antagonist in human oral squamous cell carcinoma bone invasion mouse model.
RESULTS:NK-3R was significantly expressed in tumor cells that had invaded the bone matrix compared to the oral side tumor cells. SB222200, a selective antagonist of NK-3R, significantly suppressed the radiographic osteolytic lesion and tumorigenesis.
CONCLUSION:NK-3R signaling is a potential target for the treatment of oral squamous cell carcinoma in cases of bone destruction.
巻・号 37(11)
ページ 6119-6123
公開日 2017-11-1
DOI 10.21873/anticanres.12060
PII 37/11/6119
PMID 29061792
MeSH Animals Apoptosis / drug effects Bone Resorption / drug therapy Bone Resorption / metabolism Bone Resorption / pathology* Carcinoma, Squamous Cell / drug therapy Carcinoma, Squamous Cell / metabolism Carcinoma, Squamous Cell / pathology* Cell Movement / drug effects Cell Proliferation / drug effects Gene Expression Regulation, Neoplastic / drug effects Humans Male Mice Mice, Inbred BALB C Mice, Nude Mouth Neoplasms / drug therapy Mouth Neoplasms / metabolism Mouth Neoplasms / pathology* Prognosis Quinolines / pharmacology Receptors, Neurokinin-3 / antagonists & inhibitors Receptors, Neurokinin-3 / metabolism* Retrospective Studies Tumor Cells, Cultured Xenograft Model Antitumor Assays
IF 1.994
引用数 1
リソース情報
ヒト・動物細胞 HSC-2(RCB1945)